340B ACCESS Act

This bill appears to concern the 340B drug pricing program, which is a federal program that requires drug manufacturers to provide discounts on medications to certain healthcare providers. The bill's title suggests it deals with access to this program, but the specific changes or provisions are unclear from the title alone. No official summary is available for this bill.

Your Vote